Backhaus, J, Junghanns, K, Broocks, A, et al. (2002) Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. Journal of Psychosomatic Research 53: 737–740.
Google Scholar | Crossref | Medline | ISI Baumann, MH, Wang, X, Rothman, RB (2007) 3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: A reappraisal of past and present findings. Psychopharmacology 189: 407–424.
Google Scholar | Crossref | Medline | ISI Bershad, AK, Mayo, LM, Van Hedger, K, et al. (2019) Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacology 44: 1698–1705.
Google Scholar | Crossref | Medline Borissova, A, Ferguson, B, Wall, MB, et al. (2020) Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology 35: 547–555.
Google Scholar | SAGE Journals Carhart-Harris, RL, Murphy, K, Leech, R, et al. (2015) The effects of acutely administered 3, 4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level–dependent resting state functional connectivity. Biological Psychiatry 78: 554–562.
Google Scholar | Crossref | Medline Curran, HV, Travill, RA (1997) Mood and cognitive effects of ±3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): Week-end ‘high’ followed by mid-week low. Addiction 92: 821–831.
Google Scholar | Medline | ISI De La Garza, R, Fabrizio, KR, Gupta, A (2007) Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology 189: 425–434.
Google Scholar | Crossref | Medline de Wit, H, Bershad, AK, Grob, C (2021) Challenges in translational research: MDMA in the laboratory versus therapeutic settings. Journal of Psychopharmacology. Epub ahead of print 4 May. DOI: 10.1177/02698811211015221.
Google Scholar | SAGE Journals Doblin, R (2002) A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): Partnering with the FDA. Journal of Psychoactive Drugs 34: 185–194.
Google Scholar | Crossref | Medline Drugs Information Monitoring System (DIMS) (2021) Annual Report 2020. Utrecht: Trimbos-instituut.
Google Scholar Freye, E (2009) Pharmacological effects of MDMA in man. In: Freye, E (ed.) Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Dordrecht: Springer, pp.151–160.
Google Scholar | Crossref Gibson, SJ (1997) The measurement of mood states in older adults. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 52: 167–174.
Google Scholar | Crossref | Medline | ISI Heifets, BD, Malenka, RC (2021) Better living through chemistry: MDMA’s prosocial mechanism as a starting point for improved therapeutics. Neuropsychopharmacology 46: 261.
Google Scholar | Crossref | Medline Jerome, L, Feduccia, AA, Wang, JB, et al. (2020) Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: A longitudinal pooled analysis of six phase 2 trials. Psychopharmacology 237: 2485–2497.
Google Scholar | Crossref | Medline Koob, GF, Colrain, IM (2020) Alcohol use disorder and sleep disturbances: A feed-forward allostatic framework. Neuropsychopharmacology 45: 141–165.
Google Scholar | Crossref | Medline McCormack, M, Measham, F, Wignall, L (2021) The normalization of leisure sex and recreational drugs: Exploring associations between polydrug use and sexual practices by English festival-goers. Contemporary Drug Problems 48: 185–200.
Google Scholar | SAGE Journals Measham, F (2019) Drug safety testing, disposals and dealing in an English field: Exploring the operational and behavioural outcomes of the UK’s first onsite ‘drug checking’ service. International Journal of Drug Policy 67: 102–107.
Google Scholar | Crossref | Medline Measham, F (2020) The NPS imposters, merging and emerging drug markets and the contribution of drug checking. In: Bewley-Taylor, D, Tinasti, K (eds) Research Handbook on International Drug Policy. Cheltenham: Edward Elgar, pp.341–354.
Google Scholar | Crossref Measham, F, Aldridge, J, Parker, H (2001) Dancing on Drugs: Risk, Health and Hedonism in the British Club Scene. London: Free Association Books.
Google Scholar Mitchell, JM, Bogenschutz, M, Lilienstein, A, et al. (2021) MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine 27: 1025–1033.
Google Scholar | Crossref | Medline Mithoefer, MC, Mithoefer, AT, Feduccia, AA, et al. (2018) 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: A randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry 5: 486–497.
Google Scholar | Crossref | Medline Parrott, AC, Lasky, J (1998) Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance. Psychopharmacology 139: 261–268.
Google Scholar | Crossref | Medline | ISI Passie, T, Benzenhöfer, U (2016) The history of MDMA as an underground drug in the United States, 1960–1979. Journal of Psychoactive Drugs 48: 67–75.
Google Scholar | Crossref | Medline Ricaurte, G, Bryan, G, Strauss, L, et al. (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229(4717): 986–988.
Google Scholar | Crossref | Medline Ricaurte, GA, Yuan, J, Hatzidimitriou, G, et al. (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (‘ecstasy’). Science 297: 2260–2263.
Google Scholar | Crossref | Medline | ISI Safer Party (2021) Takeshi 69 test results. Available at: https://www.saferparty.ch/231.html
Google Scholar Sessa, B (2019) Therapeutic applications of 3, 4-methylenedioxymethamphetamine (MDMA). In: Winkelman, M, Sessa, B (eds) Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications. Santa Barbara, CA: ABC-CLIO, p.43.
Google Scholar Sessa, B, Nutt, DJ (2007) MDMA, politics and medical research: Have we thrown the baby out with the bathwater? Journal of Psychopharmacology 21: 787–791.
Google Scholar | SAGE Journals | ISI Sessa, B, Nutt, DJ (2015) Making a medicine out of MDMA. The British Journal of Psychiatry 206: 4–6.
Google Scholar | Crossref | Medline Sessa, B, Higbed, L, O’Brien, S, et al. (2021) First study of safety and tolerability of 3, 4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. Journal of Psychopharmacology 35: 375–383.
Google Scholar | SAGE Journals | ISI Stolaroff, M (2004) The Secret Chief Revealed: Conversations with a Pioneer of the Underground Therapy Movement. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies.
Google Scholar Terry, PC, Lane, AM, Fogarty, GJ (2003) Construct validity of the Profile of Mood States – Adolescents for use with adults. Psychology of Sport and Exercise 4: 125–139.
Google Scholar | Crossref | ISI Thakkar, MM, Sharma, R, Sahota, P (2015) Alcohol disrupts sleep homeostasis. Alcohol 49: 299–310.
Google Scholar | Crossref | Medline Verheyden, SL, Henry, JA, Curran, HV (2003) Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users. Human Psychopharmacology: Clinical and Experimental 18: 507–517.
Google Scholar | Crossref | Medline | ISI Vollenweider, FX, Gamma, A, Liechti, M, et al. (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (‘ecstasy’) in MDMA-naïve healthy volunteers. Neuropsychopharmacology 19: 241–251.
Google Scholar | Crossref | Medline | ISI Wolfson, PE, Andries, J, Feduccia, AA, et al. (2020) MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: A randomized pilot study. Scientific Reports 10: 1–15.
Google Scholar | Crossref | Medline